Form 4 for EW Edwards Lifesciences
Accepted 2023-09-14 00:00:00 ET · period of report 2023-09-14 · accession 0001225208-23-008936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-14 | 2023-09-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $73.63 | -8,660 | 213.8K | -4% | -$637.6K |
| D | 2023-09-14 | 2023-09-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +8,660 | 222.5K | +4% | +$392.1K |
| D | 2023-09-14 | 2023-09-14 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $0.00 | -8,660 | 26.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-14 | S | D | 8,660 | $73.63 | 213,793.71 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $73.23 to $73.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-09-14 | M | A | 8,660 | $45.28 | 222,453.71 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-09-14 | M | D | 8,660 | $0.00 | 25,978 | D | $45.28 · 2019-05-17 to 2025-05-16 | 8,660 Common Stock |